A gene study of 300,000 veterans yields three cholesterol-controlling mutations that could help develop new drugs for diabetes and cardiovascular disease.
A gene study of 300,000 veterans yields three cholesterol-controlling mutations that could help develop new drugs for diabetes and cardiovascular disease.